Skip to main content
SpringerLink
Log in

Elevated liver enzymes in serum during suloctidil treatment

  • Short Communication
  • Published:
European Journal of Clinical Pharmacology Aims and scope Submit manuscript

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

References

  1. Gaetano G de, Miragliotta G, Roncucci R, Lansen J, Lambelin G (1976) Suloctidil: A novel inhibitor of platelet aggregation in human beings. Thromb Res 8: 361–371

    Article  PubMed  Google Scholar 

  2. Gurewich V, Lipinski B (1976) Evaluation of the antithrombotic properties of suloctidil in comparison with aspirin and dipyridamole. Thromb Res 9: 101–108

    Article  PubMed  CAS  Google Scholar 

  3. Verhaeghe R, Hoof A van, Beyens Gh (1981) Controlled trial of suloctidil in intermittent claudication. J Cardiovasc Pharmacol 3: 279–286

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Internal Medicine, Free University Hospital, Amsterdam, The Netherlands

    J. A. Schouten & R. F. Westerman

Authors
  1. J. A. Schouten
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. R. F. Westerman
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Schouten, J.A., Westerman, R.F. Elevated liver enzymes in serum during suloctidil treatment. Eur J Clin Pharmacol 22, 559–560 (1982). https://doi.org/10.1007/BF00609631

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF00609631

Key words

Search

Navigation